Contributors

Meet some of the people featured in the July 2012 issue of The Scientist.


Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Keith D. Wilkinson (far left) began studying the ubiquitin pathway in 1979 because it was “brand new.” He was recruited to Nobel Prize–winner Irwin Rose’s lab at the Fox Chase Cancer Center just a few short years after ubiquitin was first discovered. Today, Wilkinson is still figuring out the mysteries of a protein that is found in all eukaryotic cells and is fundamental to the cell cycle. He is currently identifying a host of enzymes that regulate ubiquitin-dependent processes, with the expectation that the enzymes will be good drug targets in disease. Wilkinson first met his coauthor David Fushman at a biannual ubiquitin meeting, where “everybody who is anybody in this field got their start.” Chains of ubiquitin are only distinguished by their pattern of connections, and Fushman wants to understand how the connections affect the signaling process. In their feature article, "On the Chain Gang," you can read about ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
TS Digest January 2025
January 2025, Issue 1

Why Do Some People Get Drunk Faster Than Others?

Genetics and tolerance shake up how alcohol affects each person, creating a unique cocktail of experiences.

View this Issue
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo
New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Sino
New Approaches for Decoding Cancer at the Single-Cell Level

New Approaches for Decoding Cancer at the Single-Cell Level

Biotium logo
Learn How 3D Cell Cultures Advance Tissue Regeneration

Organoids as a Tool for Tissue Regeneration Research 

Acro 

Products

Artificial Inc. Logo

Artificial Inc. proof-of-concept data demonstrates platform capabilities with NVIDIA’s BioNeMo

Sapient Logo

Sapient Partners with Alamar Biosciences to Extend Targeted Proteomics Services Using NULISA™ Assays for Cytokines, Chemokines, and Inflammatory Mediators

Bio-Rad Logo

Bio-Rad Extends Range of Vericheck ddPCR Empty-Full Capsid Kits to Optimize AAV Vector Characterization

Scientist holding a blood sample tube labeled Mycoplasma test in front of many other tubes containing patient samples

Accelerating Mycoplasma Testing for Targeted Therapy Development